Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Kallikrein 4/Prostase/EMSP1 Antibody (104), DyLight 594, Novus Biologicals™
SDP

Rabbit Monoclonal Antibody

Supplier:  Novus Biologicals NBP290008DL594

Catalog No. NB068851


Only null left
Add to Cart

Description

Description

Kallikrein 4/Prostase/EMSP1 Monoclonal specifically detects Kallikrein 4/Prostase/EMSP1 in Human samples. It is validated for ELISA.
Specifications

Specifications

Kallikrein 4/Prostase/EMSP1
Monoclonal
DyLight 594
50mM Sodium Borate
Rabbit
Protein A purified
RUO
Primary
No cross-reactivity in ELISA with: Human KLK1 Human KLK3 Human KLK7 Human KLK8 Human KLK11 Human KLK13 Human Factor X Human HGFA Human UPA-1 Human KLK6
Store at 4°C in the dark.
IgG
ELISA
104
ELISA
AI2A1, ARM1, EC 3.4.21, EC 3.4.21.-, EMSP, EMSP1MGC116827, Enamel matrix serine proteinase 1, kallikrein 4 (prostase, enamel matrix, prostate), kallikrein-4, Kallikrein-like protein 1, kallikrein-related peptidase 4, KLK-L1MGC116828, Prostase, PRSS17enamel matrix serine protease 1, PSTSandrogen-regulated message 1, Serine protease 17
This antibody was obtained from a rabbit immunized with purified, recombinant Human Kallikrein 4/Prostase/EMSP1 (NP_004908.3; Met1-Ser254).
0.1 mL
Apoptosis, Cancer, Tumor Suppressors
9622
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.